

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Golgi transport vesicle coating (GO:0048200) | 9.00463744 |
| 2 | COPI coating of Golgi vesicle (GO:0048205) | 9.00463744 |
| 3 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 8.06590845 |
| 4 | protein retention in ER lumen (GO:0006621) | 7.71769427 |
| 5 | exocrine pancreas development (GO:0031017) | 6.52973568 |
| 6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.88673921 |
| 7 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.88673921 |
| 8 | modulation by symbiont of host immune response (GO:0052553) | 5.88673921 |
| 9 | positive regulation by symbiont of host defense response (GO:0052509) | 5.88673921 |
| 10 | modulation by symbiont of host defense response (GO:0052031) | 5.88673921 |
| 11 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.88673921 |
| 12 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 5.47133443 |
| 13 | signal peptide processing (GO:0006465) | 5.36822301 |
| 14 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.34719933 |
| 15 | neutrophil activation (GO:0042119) | 5.16866628 |
| 16 | detection of other organism (GO:0098543) | 5.16351697 |
| 17 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.11306884 |
| 18 | negative regulation of cell killing (GO:0031342) | 5.11306884 |
| 19 | detection of bacterium (GO:0016045) | 4.93558305 |
| 20 | sequestering of metal ion (GO:0051238) | 4.81229771 |
| 21 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 4.80302771 |
| 22 | intestinal cholesterol absorption (GO:0030299) | 4.80289788 |
| 23 | protein maturation by protein folding (GO:0022417) | 4.78466699 |
| 24 | COPII vesicle coating (GO:0048208) | 4.72530299 |
| 25 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.64929803 |
| 26 | endocrine pancreas development (GO:0031018) | 4.62898227 |
| 27 | mitochondrial calcium ion transport (GO:0006851) | 4.57717830 |
| 28 | positive regulation of nuclease activity (GO:0032075) | 4.57506913 |
| 29 | keratinocyte development (GO:0003334) | 4.53415913 |
| 30 | glandular epithelial cell differentiation (GO:0002067) | 4.46948515 |
| 31 | macrophage activation involved in immune response (GO:0002281) | 4.42981352 |
| 32 | digestion (GO:0007586) | 4.40799353 |
| 33 | microglial cell activation (GO:0001774) | 4.36694905 |
| 34 | granulocyte activation (GO:0036230) | 4.35175723 |
| 35 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 4.35077065 |
| 36 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 4.33007833 |
| 37 | detection of external biotic stimulus (GO:0098581) | 4.28634818 |
| 38 | response to host immune response (GO:0052572) | 4.27076299 |
| 39 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.27076299 |
| 40 | leukocyte aggregation (GO:0070486) | 4.17975588 |
| 41 | regulation of nuclease activity (GO:0032069) | 4.15608448 |
| 42 | endoplasmic reticulum unfolded protein response (GO:0030968) | 4.15183587 |
| 43 | peptide hormone processing (GO:0016486) | 4.13721875 |
| 44 | detection of molecule of bacterial origin (GO:0032490) | 4.11552184 |
| 45 | cellular response to unfolded protein (GO:0034620) | 4.05729185 |
| 46 | respiratory burst (GO:0045730) | 4.03881208 |
| 47 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.00556603 |
| 48 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.98531482 |
| 49 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 3.96462809 |
| 50 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.95760742 |
| 51 | cellular response to topologically incorrect protein (GO:0035967) | 3.95482427 |
| 52 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.95416679 |
| 53 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.92662452 |
| 54 | cellular extravasation (GO:0045123) | 3.92065252 |
| 55 | ER-nucleus signaling pathway (GO:0006984) | 3.88389103 |
| 56 | intestinal epithelial cell development (GO:0060576) | 3.86530397 |
| 57 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.83706089 |
| 58 | desmosome organization (GO:0002934) | 3.82345467 |
| 59 | macrophage activation (GO:0042116) | 3.78007425 |
| 60 | transcytosis (GO:0045056) | 3.77585192 |
| 61 | type B pancreatic cell development (GO:0003323) | 3.75312108 |
| 62 | response to host (GO:0075136) | 3.64805532 |
| 63 | response to host defenses (GO:0052200) | 3.64805532 |
| 64 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.64805532 |
| 65 | detection of biotic stimulus (GO:0009595) | 3.63363680 |
| 66 | protein N-linked glycosylation via asparagine (GO:0018279) | 3.61131163 |
| 67 | response to endoplasmic reticulum stress (GO:0034976) | 3.61015388 |
| 68 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.58862124 |
| 69 | vesicle coating (GO:0006901) | 3.58340836 |
| 70 | peptidyl-asparagine modification (GO:0018196) | 3.58109122 |
| 71 | negative regulation of phagocytosis (GO:0050765) | 3.56944083 |
| 72 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.56079568 |
| 73 | ER overload response (GO:0006983) | 3.53777626 |
| 74 | intestinal absorption (GO:0050892) | 3.50825100 |
| 75 | myeloid cell activation involved in immune response (GO:0002275) | 3.49023989 |
| 76 | leukocyte degranulation (GO:0043299) | 3.45447038 |
| 77 | cellular response to interleukin-15 (GO:0071350) | 3.43932507 |
| 78 | hepatocyte apoptotic process (GO:0097284) | 3.43841505 |
| 79 | columnar/cuboidal epithelial cell development (GO:0002066) | 3.41970567 |
| 80 | sphingosine metabolic process (GO:0006670) | 3.41133113 |
| 81 | interleukin-1-mediated signaling pathway (GO:0070498) | 3.39404254 |
| 82 | glandular epithelial cell development (GO:0002068) | 3.37121896 |
| 83 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.36306430 |
| 84 | regulation of water loss via skin (GO:0033561) | 3.33601327 |
| 85 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 3.31403845 |
| 86 | response to interleukin-15 (GO:0070672) | 3.27687166 |
| 87 | protein N-linked glycosylation (GO:0006487) | 3.25972393 |
| 88 | negative regulation of T cell mediated immunity (GO:0002710) | 3.24108789 |
| 89 | diol metabolic process (GO:0034311) | 3.23925729 |
| 90 | dendritic cell migration (GO:0036336) | 3.23153423 |
| 91 | negative regulation of interleukin-12 production (GO:0032695) | 3.22194568 |
| 92 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.20151251 |
| 93 | sphingoid metabolic process (GO:0046519) | 3.18246984 |
| 94 | regulation of gamma-delta T cell activation (GO:0046643) | 3.17615110 |
| 95 | interferon-gamma secretion (GO:0072643) | 3.16755087 |
| 96 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.16538572 |
| 97 | valine metabolic process (GO:0006573) | 3.16330191 |
| 98 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.15155082 |
| 99 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.15155082 |
| 100 | peptide catabolic process (GO:0043171) | 3.14401277 |
| 101 | immunoglobulin mediated immune response (GO:0016064) | 3.11318736 |
| 102 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.09524704 |
| 103 | GDP-mannose metabolic process (GO:0019673) | 3.08410335 |
| 104 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.06387162 |
| 105 | nucleoside diphosphate catabolic process (GO:0009134) | 3.06188852 |
| 106 | regulation of mast cell degranulation (GO:0043304) | 3.05445553 |
| 107 | regulation of mast cell activation (GO:0033003) | 3.05203630 |
| 108 | positive regulation of mast cell activation (GO:0033005) | 3.02322575 |
| 109 | eosinophil chemotaxis (GO:0048245) | 2.99277459 |
| 110 | neutrophil mediated immunity (GO:0002446) | 2.99112851 |
| 111 | response to unfolded protein (GO:0006986) | 2.98972167 |
| 112 | response to peptidoglycan (GO:0032494) | 2.97583403 |
| 113 | ceramide catabolic process (GO:0046514) | 2.97105230 |
| 114 | fucose metabolic process (GO:0006004) | 2.96983537 |
| 115 | multicellular organismal water homeostasis (GO:0050891) | 2.94410309 |
| 116 | insulin secretion (GO:0030073) | 2.93178359 |
| 117 | establishment of skin barrier (GO:0061436) | 2.93062637 |
| 118 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.91911192 |
| 119 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.90879908 |
| 120 | response to topologically incorrect protein (GO:0035966) | 2.90626411 |
| 121 | positive regulation of insulin secretion (GO:0032024) | 2.90446321 |
| 122 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.88517409 |
| 123 | hemidesmosome assembly (GO:0031581) | 2.85914511 |
| 124 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.85468782 |
| 125 | negative regulation of interleukin-1 production (GO:0032692) | 2.84940508 |
| 126 | ER to Golgi vesicle-mediated transport (GO:0006888) | 2.84717584 |
| 127 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.84292117 |
| 128 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.84292117 |
| 129 | adaptation of signaling pathway (GO:0023058) | 2.80248264 |
| 130 | regulation of Cdc42 GTPase activity (GO:0043088) | 2.79908796 |
| 131 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.79267297 |
| 132 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.78881783 |
| 133 | negative regulation of interleukin-6 production (GO:0032715) | 2.78434213 |
| 134 | maintenance of protein localization in organelle (GO:0072595) | 2.78402609 |
| 135 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.77027410 |
| 136 | cellular response to vitamin D (GO:0071305) | 2.76803418 |
| 137 | neutrophil chemotaxis (GO:0030593) | 2.76627469 |
| 138 | leukotriene biosynthetic process (GO:0019370) | 2.76448366 |
| 139 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.75838288 |
| 140 | cell wall macromolecule catabolic process (GO:0016998) | 2.75589479 |
| 141 | eosinophil migration (GO:0072677) | 2.75287265 |
| 142 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.75264265 |
| 143 | positive regulation of vesicle fusion (GO:0031340) | 2.75148930 |
| 144 | neutrophil activation involved in immune response (GO:0002283) | 2.75142096 |
| 145 | intra-Golgi vesicle-mediated transport (GO:0006891) | 2.73406272 |
| 146 | dendritic cell chemotaxis (GO:0002407) | 2.73022388 |
| 147 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 2.72946196 |
| 148 | superoxide anion generation (GO:0042554) | 2.71857951 |
| 149 | membrane budding (GO:0006900) | 2.71739125 |
| 150 | regulation of leukocyte degranulation (GO:0043300) | 2.71254811 |
| 151 | neutrophil migration (GO:1990266) | 2.69434101 |
| 152 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.69061057 |
| 153 | positive regulation of interferon-alpha production (GO:0032727) | 2.65340596 |
| 154 | regulated secretory pathway (GO:0045055) | 2.65302577 |
| 155 | Golgi organization (GO:0007030) | 2.63453949 |
| 156 | regulation of phospholipase A2 activity (GO:0032429) | 2.62181722 |
| 157 | glucosamine-containing compound catabolic process (GO:1901072) | 2.60940311 |
| 158 | activated T cell proliferation (GO:0050798) | 2.60910771 |
| 159 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.58857739 |
| 160 | negative regulation of B cell mediated immunity (GO:0002713) | 2.58599777 |
| 161 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.58599777 |
| 162 | negative regulation of adaptive immune response (GO:0002820) | 2.58248277 |
| 163 | membrane lipid catabolic process (GO:0046466) | 2.57953235 |
| 164 | reactive oxygen species biosynthetic process (GO:1903409) | 2.57780867 |
| 165 | myeloid leukocyte activation (GO:0002274) | 2.55627079 |
| 166 | phagosome maturation (GO:0090382) | 2.55299211 |
| 167 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.54544171 |
| 168 | leukotriene metabolic process (GO:0006691) | 2.54300362 |
| 169 | gland morphogenesis (GO:0022612) | 2.54171196 |
| 170 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.54085040 |
| 171 | glycolipid catabolic process (GO:0019377) | 2.54039231 |
| 172 | phospholipid scrambling (GO:0017121) | 2.52609219 |
| 173 | water homeostasis (GO:0030104) | 2.52308244 |
| 174 | regulation of insulin secretion (GO:0050796) | 2.52124263 |
| 175 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.49830774 |
| 176 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.49150533 |
| 177 | zinc ion transport (GO:0006829) | 2.49010734 |
| 178 | cellular response to nicotine (GO:0071316) | 2.45303797 |
| 179 | cellular response to vitamin (GO:0071295) | 2.45169517 |
| 180 | cellular response to antibiotic (GO:0071236) | 2.44171197 |
| 181 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.43587344 |
| 182 | negative regulation of glycoprotein metabolic process (GO:1903019) | 2.43362206 |
| 183 | norepinephrine metabolic process (GO:0042415) | 2.42349811 |
| 184 | epithelial cell maturation (GO:0002070) | 2.41900741 |
| 185 | growth hormone receptor signaling pathway (GO:0060396) | 2.38348574 |
| 186 | myeloid leukocyte mediated immunity (GO:0002444) | 2.38085608 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 6.38072340 |
| 2 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.42004854 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.71122036 |
| 4 | GATA1_22025678_ChIP-Seq_K562_Human | 3.61083752 |
| 5 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.97046297 |
| 6 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.64712756 |
| 7 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.52156243 |
| 8 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.16522539 |
| 9 | * SOX2_20726797_ChIP-Seq_SW620_Human | 2.14418103 |
| 10 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.09307834 |
| 11 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.08928355 |
| 12 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.04443585 |
| 13 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.98986860 |
| 14 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.98564883 |
| 15 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.96701132 |
| 16 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.95488571 |
| 17 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.95353039 |
| 18 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.93525185 |
| 19 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.92752981 |
| 20 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.92315798 |
| 21 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.91836210 |
| 22 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.89155886 |
| 23 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.88319433 |
| 24 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.75961990 |
| 25 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.74582970 |
| 26 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.74299185 |
| 27 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.73979464 |
| 28 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.72703032 |
| 29 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.64223357 |
| 30 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.63381047 |
| 31 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.62646439 |
| 32 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.62255364 |
| 33 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.60375304 |
| 34 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.58848941 |
| 35 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.58800381 |
| 36 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 1.57985872 |
| 37 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.57173486 |
| 38 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.55372020 |
| 39 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.55224102 |
| 40 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.54654555 |
| 41 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.54475869 |
| 42 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.53987905 |
| 43 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.52978168 |
| 44 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.52352598 |
| 45 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.47934544 |
| 46 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.40999682 |
| 47 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.40961349 |
| 48 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.40639337 |
| 49 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.38205207 |
| 50 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.37874120 |
| 51 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.37616154 |
| 52 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36919544 |
| 53 | MYB_26560356_Chip-Seq_TH1_Human | 1.36180883 |
| 54 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.35598503 |
| 55 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.34401193 |
| 56 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.32881832 |
| 57 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.32753764 |
| 58 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31795043 |
| 59 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31224810 |
| 60 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.29812463 |
| 61 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.29271821 |
| 62 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.28059066 |
| 63 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.27449105 |
| 64 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.25299337 |
| 65 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.24899424 |
| 66 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.24868343 |
| 67 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.22028580 |
| 68 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.22028580 |
| 69 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.20072074 |
| 70 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.19878650 |
| 71 | * RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.19744332 |
| 72 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.19627195 |
| 73 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.19381729 |
| 74 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.19341913 |
| 75 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.19097915 |
| 76 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.18910912 |
| 77 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.17821150 |
| 78 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.16500867 |
| 79 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.14860210 |
| 80 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.14663738 |
| 81 | ELF5_23300383_ChIP-Seq_T47D_Human | 1.12088945 |
| 82 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.12003320 |
| 83 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.11856596 |
| 84 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.11274538 |
| 85 | CJUN_26792858_Chip-Seq_BT549_Human | 1.10496063 |
| 86 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.10113384 |
| 87 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.10017183 |
| 88 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.09560965 |
| 89 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.08500852 |
| 90 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.08001694 |
| 91 | SPI1_23127762_ChIP-Seq_K562_Human | 1.07396733 |
| 92 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.05232871 |
| 93 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04306592 |
| 94 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.04192335 |
| 95 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.03440804 |
| 96 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.03252637 |
| 97 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.02146369 |
| 98 | MYB_26560356_Chip-Seq_TH2_Human | 1.01446959 |
| 99 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.01286484 |
| 100 | UTX_26944678_Chip-Seq_JUKART_Human | 1.01211834 |
| 101 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.01180809 |
| 102 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00838724 |
| 103 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00317077 |
| 104 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.00310839 |
| 105 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.99678985 |
| 106 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.98370692 |
| 107 | GATA3_26560356_Chip-Seq_TH2_Human | 0.96557766 |
| 108 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.96547895 |
| 109 | GATA2_19941826_ChIP-Seq_K562_Human | 0.96395356 |
| 110 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96149874 |
| 111 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.95596666 |
| 112 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.94823448 |
| 113 | ATF3_27146783_Chip-Seq_COLON_Human | 0.94451740 |
| 114 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.93684189 |
| 115 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.92794328 |
| 116 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.92740370 |
| 117 | MAF_26560356_Chip-Seq_TH1_Human | 0.92309511 |
| 118 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.91808766 |
| 119 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.91677649 |
| 120 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.91667053 |
| 121 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.90906120 |
| 122 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.90456336 |
| 123 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.90006732 |
| 124 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.89827757 |
| 125 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.89487289 |
| 126 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.89171222 |
| 127 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.89147119 |
| 128 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.89120938 |
| 129 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.88983376 |
| 130 | HOXB7_26014856_ChIP-Seq_BT474_Human | 0.88969977 |
| 131 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.88952755 |
| 132 | GATA1_19941826_ChIP-Seq_K562_Human | 0.88910868 |
| 133 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.88861675 |
| 134 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.88861675 |
| 135 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.87333210 |
| 136 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.87284012 |
| 137 | AR_20517297_ChIP-Seq_VCAP_Human | 0.86862562 |
| 138 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.86812831 |
| 139 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.86810062 |
| 140 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.86808366 |
| 141 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.86661923 |
| 142 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.86638883 |
| 143 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.86340477 |
| 144 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.86010321 |
| 145 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.85492148 |
| 146 | ERA_21632823_ChIP-Seq_H3396_Human | 0.84824259 |
| 147 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.84551590 |
| 148 | * VDR_24763502_ChIP-Seq_THP-1_Human | 0.84492751 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002877_abnormal_melanocyte_morpholog | 3.95068317 |
| 2 | MP0005220_abnormal_exocrine_pancreas | 3.56665280 |
| 3 | MP0010386_abnormal_urinary_bladder | 3.55577172 |
| 4 | MP0004381_abnormal_hair_follicle | 3.53615738 |
| 5 | MP0002693_abnormal_pancreas_physiology | 3.50672084 |
| 6 | MP0003183_abnormal_peptide_metabolism | 3.27589631 |
| 7 | MP0001666_abnormal_nutrient_absorption | 3.03118683 |
| 8 | MP0003191_abnormal_cellular_cholesterol | 2.98877345 |
| 9 | MP0010234_abnormal_vibrissa_follicle | 2.93005386 |
| 10 | MP0005075_abnormal_melanosome_morpholog | 2.73693282 |
| 11 | MP0001944_abnormal_pancreas_morphology | 2.72337837 |
| 12 | MP0004264_abnormal_extraembryonic_tissu | 2.71677597 |
| 13 | MP0003787_abnormal_imprinting | 2.70096824 |
| 14 | MP0005083_abnormal_biliary_tract | 2.55540976 |
| 15 | MP0005379_endocrine/exocrine_gland_phen | 2.41343182 |
| 16 | MP0002909_abnormal_adrenal_gland | 2.35199204 |
| 17 | MP0003300_gastrointestinal_ulcer | 2.12795504 |
| 18 | MP0003436_decreased_susceptibility_to | 2.00475348 |
| 19 | MP0009780_abnormal_chondrocyte_physiolo | 1.99997911 |
| 20 | MP0002796_impaired_skin_barrier | 1.99820919 |
| 21 | MP0008004_abnormal_stomach_pH | 1.99206375 |
| 22 | MP0000465_gastrointestinal_hemorrhage | 1.99156583 |
| 23 | MP0000427_abnormal_hair_cycle | 1.97161738 |
| 24 | MP0000678_abnormal_parathyroid_gland | 1.93968283 |
| 25 | MP0001800_abnormal_humoral_immune | 1.92956368 |
| 26 | MP0008260_abnormal_autophagy | 1.89138284 |
| 27 | MP0005310_abnormal_salivary_gland | 1.88847300 |
| 28 | MP0000013_abnormal_adipose_tissue | 1.83325579 |
| 29 | MP0002132_abnormal_respiratory_system | 1.79824847 |
| 30 | MP0010678_abnormal_skin_adnexa | 1.79343419 |
| 31 | MP0001986_abnormal_taste_sensitivity | 1.77094654 |
| 32 | MP0002420_abnormal_adaptive_immunity | 1.76010388 |
| 33 | MP0001819_abnormal_immune_cell | 1.74783216 |
| 34 | MP0006054_spinal_hemorrhage | 1.73362570 |
| 35 | MP0002837_dystrophic_cardiac_calcinosis | 1.73220053 |
| 36 | MP0000015_abnormal_ear_pigmentation | 1.72785050 |
| 37 | MP0002009_preneoplasia | 1.71597475 |
| 38 | MP0000613_abnormal_salivary_gland | 1.71544378 |
| 39 | MP0003868_abnormal_feces_composition | 1.70202368 |
| 40 | MP0002723_abnormal_immune_serum | 1.67589418 |
| 41 | MP0000569_abnormal_digit_pigmentation | 1.66791014 |
| 42 | MP0003283_abnormal_digestive_organ | 1.66019894 |
| 43 | MP0002452_abnormal_antigen_presenting | 1.59931377 |
| 44 | MP0005058_abnormal_lysosome_morphology | 1.57824700 |
| 45 | MP0004043_abnormal_pH_regulation | 1.56672835 |
| 46 | MP0005671_abnormal_response_to | 1.56512612 |
| 47 | MP0002078_abnormal_glucose_homeostasis | 1.55660880 |
| 48 | MP0005365_abnormal_bile_salt | 1.54109200 |
| 49 | MP0002638_abnormal_pupillary_reflex | 1.53412705 |
| 50 | MP0005275_abnormal_skin_tensile | 1.52317235 |
| 51 | MP0003724_increased_susceptibility_to | 1.50748209 |
| 52 | MP0005248_abnormal_Harderian_gland | 1.50019519 |
| 53 | MP0002060_abnormal_skin_morphology | 1.49498185 |
| 54 | MP0004883_abnormal_blood_vessel | 1.48655087 |
| 55 | MP0003011_delayed_dark_adaptation | 1.48209908 |
| 56 | MP0002148_abnormal_hypersensitivity_rea | 1.48187475 |
| 57 | MP0002876_abnormal_thyroid_physiology | 1.46051053 |
| 58 | MP0004782_abnormal_surfactant_physiolog | 1.45783453 |
| 59 | MP0001664_abnormal_digestion | 1.42699165 |
| 60 | MP0005174_abnormal_tail_pigmentation | 1.42414084 |
| 61 | MP0000383_abnormal_hair_follicle | 1.41412991 |
| 62 | MP0002166_altered_tumor_susceptibility | 1.40809683 |
| 63 | MP0000579_abnormal_nail_morphology | 1.39220222 |
| 64 | MP0004947_skin_inflammation | 1.36401998 |
| 65 | MP0003866_abnormal_defecation | 1.34963595 |
| 66 | MP0001765_abnormal_ion_homeostasis | 1.34913148 |
| 67 | MP0006082_CNS_inflammation | 1.34744248 |
| 68 | MP0008877_abnormal_DNA_methylation | 1.34338557 |
| 69 | MP0000538_abnormal_urinary_bladder | 1.32945606 |
| 70 | MP0003959_abnormal_lean_body | 1.30315061 |
| 71 | MP0000685_abnormal_immune_system | 1.29830215 |
| 72 | MP0009643_abnormal_urine_homeostasis | 1.29511562 |
| 73 | MP0002396_abnormal_hematopoietic_system | 1.28687439 |
| 74 | MP0003828_pulmonary_edema | 1.28252746 |
| 75 | MP0001756_abnormal_urination | 1.24864945 |
| 76 | MP0002098_abnormal_vibrissa_morphology | 1.22050597 |
| 77 | MP0001533_abnormal_skeleton_physiology | 1.21988693 |
| 78 | MP0004185_abnormal_adipocyte_glucose | 1.21485890 |
| 79 | MP0002163_abnormal_gland_morphology | 1.21014452 |
| 80 | MP0001216_abnormal_epidermal_layer | 1.19480411 |
| 81 | MP0003195_calcinosis | 1.19072391 |
| 82 | MP0005084_abnormal_gallbladder_morpholo | 1.18142963 |
| 83 | MP0001873_stomach_inflammation | 1.16571321 |
| 84 | MP0002405_respiratory_system_inflammati | 1.16174523 |
| 85 | MP0000003_abnormal_adipose_tissue | 1.15813207 |
| 86 | MP0000377_abnormal_hair_follicle | 1.15056553 |
| 87 | MP0000716_abnormal_immune_system | 1.14813060 |
| 88 | MP0001845_abnormal_inflammatory_respons | 1.13589988 |
| 89 | MP0003566_abnormal_cell_adhesion | 1.12110698 |
| 90 | MP0002398_abnormal_bone_marrow | 1.10219003 |
| 91 | MP0000516_abnormal_urinary_system | 1.09125017 |
| 92 | MP0005367_renal/urinary_system_phenotyp | 1.09125017 |
| 93 | MP0001835_abnormal_antigen_presentation | 1.08339021 |
| 94 | MP0004484_altered_response_of | 1.08172471 |
| 95 | MP0002006_tumorigenesis | 1.08043151 |
| 96 | MP0000689_abnormal_spleen_morphology | 1.07659304 |
| 97 | MP0002419_abnormal_innate_immunity | 1.07331285 |
| 98 | MP0000470_abnormal_stomach_morphology | 1.06060931 |
| 99 | MP0002653_abnormal_ependyma_morphology | 1.04692945 |
| 100 | MP0003953_abnormal_hormone_level | 1.04231772 |
| 101 | MP0010155_abnormal_intestine_physiology | 1.03425271 |
| 102 | MP0000681_abnormal_thyroid_gland | 1.00843757 |
| 103 | MP0005000_abnormal_immune_tolerance | 1.00615377 |
| 104 | MP0000858_altered_metastatic_potential | 0.99092916 |
| 105 | MP0001851_eye_inflammation | 0.99046904 |
| 106 | MP0009785_altered_susceptibility_to | 0.98596852 |
| 107 | MP0002254_reproductive_system_inflammat | 0.97883725 |
| 108 | MP0002138_abnormal_hepatobiliary_system | 0.97771527 |
| 109 | MP0002277_abnormal_respiratory_mucosa | 0.97719220 |
| 110 | MP0005408_hypopigmentation | 0.97057059 |
| 111 | MP0003045_fibrosis | 0.96251299 |
| 112 | MP0003303_peritoneal_inflammation | 0.95974796 |
| 113 | MP0002722_abnormal_immune_system | 0.95868641 |
| 114 | MP0002928_abnormal_bile_duct | 0.95065777 |
| 115 | MP0002896_abnormal_bone_mineralization | 0.94176284 |
| 116 | MP0005636_abnormal_mineral_homeostasis | 0.94073631 |
| 117 | MP0003453_abnormal_keratinocyte_physiol | 0.94049624 |
| 118 | MP0003943_abnormal_hepatobiliary_system | 0.93869179 |
| 119 | MP0005448_abnormal_energy_balance | 0.92589532 |
| 120 | MP0003763_abnormal_thymus_physiology | 0.92577051 |
| 121 | MP0008469_abnormal_protein_level | 0.92468927 |
| 122 | MP0005025_abnormal_response_to | 0.91925034 |
| 123 | MP0004858_abnormal_nervous_system | 0.90360776 |
| 124 | MP0001346_abnormal_lacrimal_gland | 0.90336064 |
| 125 | MP0003172_abnormal_lysosome_physiology | 0.87125298 |
| 126 | MP0005451_abnormal_body_composition | 0.83547371 |
| 127 | MP0009764_decreased_sensitivity_to | 0.83137383 |
| 128 | MP0001270_distended_abdomen | 0.82984989 |
| 129 | MP0005375_adipose_tissue_phenotype | 0.82973644 |
| 130 | MP0000703_abnormal_thymus_morphology | 0.81322992 |
| 131 | MP0003795_abnormal_bone_structure | 0.81011000 |
| 132 | MP0005535_abnormal_body_temperature | 0.80981338 |
| 133 | MP0002429_abnormal_blood_cell | 0.80320695 |
| 134 | MP0001881_abnormal_mammary_gland | 0.80260418 |
| 135 | MP0008961_abnormal_basal_metabolism | 0.79903364 |
| 136 | MP0005334_abnormal_fat_pad | 0.79890316 |
| 137 | MP0001545_abnormal_hematopoietic_system | 0.79834390 |
| 138 | MP0005397_hematopoietic_system_phenotyp | 0.79834390 |
| 139 | MP0005501_abnormal_skin_physiology | 0.78945524 |
| 140 | MP0005670_abnormal_white_adipose | 0.78031003 |
| 141 | MP0003121_genomic_imprinting | 0.77376740 |
| 142 | MP0000490_abnormal_crypts_of | 0.77284116 |
| 143 | MP0005076_abnormal_cell_differentiation | 0.76391346 |
| 144 | MP0005464_abnormal_platelet_physiology | 0.75793692 |
| 145 | MP0010771_integument_phenotype | 0.75129109 |
| 146 | MP0002118_abnormal_lipid_homeostasis | 0.73305252 |
| 147 | MP0005387_immune_system_phenotype | 0.73139227 |
| 148 | MP0001790_abnormal_immune_system | 0.73139227 |
| 149 | MP0009278_abnormal_bone_marrow | 0.72185062 |
| 150 | MP0005164_abnormal_response_to | 0.70736696 |
| 151 | MP0003878_abnormal_ear_physiology | 0.69633248 |
| 152 | MP0005377_hearing/vestibular/ear_phenot | 0.69633248 |
| 153 | MP0003638_abnormal_response/metabolism_ | 0.69174369 |
| 154 | MP0002095_abnormal_skin_pigmentation | 0.67913105 |
| 155 | MP0001919_abnormal_reproductive_system | 0.67335512 |
| 156 | MP0008995_early_reproductive_senescence | 0.66750713 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Stomatitis (HP:0010280) | 4.90822462 |
| 2 | Hypochromic microcytic anemia (HP:0004840) | 4.70156719 |
| 3 | Insulin-resistant diabetes mellitus (HP:0000831) | 4.62401841 |
| 4 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 4.54545518 |
| 5 | Hyperinsulinemic hypoglycemia (HP:0000825) | 4.53350562 |
| 6 | Hypoglycemic seizures (HP:0002173) | 4.50477333 |
| 7 | Orchitis (HP:0100796) | 4.44962211 |
| 8 | Hypoglycemic coma (HP:0001325) | 4.43208821 |
| 9 | Symptomatic seizures (HP:0011145) | 4.40955947 |
| 10 | Urinary glycosaminoglycan excretion (HP:0003541) | 4.29587588 |
| 11 | Mucopolysacchariduria (HP:0008155) | 4.29587588 |
| 12 | Retrobulbar optic neuritis (HP:0100654) | 4.16604259 |
| 13 | Optic neuritis (HP:0100653) | 4.16604259 |
| 14 | Vacuolated lymphocytes (HP:0001922) | 4.15424051 |
| 15 | Abnormality of macrophages (HP:0004311) | 4.07622889 |
| 16 | Dysostosis multiplex (HP:0000943) | 4.07473230 |
| 17 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.98442845 |
| 18 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.98442845 |
| 19 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.98442845 |
| 20 | Hypothermia (HP:0002045) | 3.82084392 |
| 21 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.76543316 |
| 22 | Hyperglycemia (HP:0003074) | 3.53077551 |
| 23 | Recurrent skin infections (HP:0001581) | 3.45536511 |
| 24 | Hypochromic anemia (HP:0001931) | 3.45515023 |
| 25 | Eczematoid dermatitis (HP:0000976) | 3.42465969 |
| 26 | Generalized aminoaciduria (HP:0002909) | 3.23592033 |
| 27 | Urticaria (HP:0001025) | 3.21229269 |
| 28 | Gastrointestinal infarctions (HP:0005244) | 3.21108945 |
| 29 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 3.21007977 |
| 30 | Exocrine pancreatic insufficiency (HP:0001738) | 3.20779077 |
| 31 | Recurrent fungal infections (HP:0002841) | 3.16828939 |
| 32 | Abnormal pancreas size (HP:0012094) | 3.12494984 |
| 33 | Late onset (HP:0003584) | 3.10208890 |
| 34 | Thoracolumbar scoliosis (HP:0002944) | 3.08876592 |
| 35 | Ketoacidosis (HP:0001993) | 3.08137090 |
| 36 | Keratoconjunctivitis sicca (HP:0001097) | 3.00966627 |
| 37 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.99290808 |
| 38 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.99290808 |
| 39 | Abnormality of the intrinsic pathway (HP:0010989) | 2.98673437 |
| 40 | Right ventricular cardiomyopathy (HP:0011663) | 2.95171633 |
| 41 | Recurrent abscess formation (HP:0002722) | 2.89832720 |
| 42 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.88839154 |
| 43 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.88839154 |
| 44 | Abnormal protein glycosylation (HP:0012346) | 2.88839154 |
| 45 | Abnormal glycosylation (HP:0012345) | 2.88839154 |
| 46 | Keratoconjunctivitis (HP:0001096) | 2.88511457 |
| 47 | Lip pit (HP:0100267) | 2.86218819 |
| 48 | Large for gestational age (HP:0001520) | 2.84097001 |
| 49 | Prolonged bleeding time (HP:0003010) | 2.80462506 |
| 50 | Chronic obstructive pulmonary disease (HP:0006510) | 2.77057341 |
| 51 | Obstructive lung disease (HP:0006536) | 2.77057341 |
| 52 | Encephalitis (HP:0002383) | 2.74883235 |
| 53 | Recurrent bacterial skin infections (HP:0005406) | 2.71337619 |
| 54 | Hyperparathyroidism (HP:0000843) | 2.69525246 |
| 55 | Amelogenesis imperfecta (HP:0000705) | 2.66231814 |
| 56 | Decreased circulating renin level (HP:0003351) | 2.64338537 |
| 57 | Meningitis (HP:0001287) | 2.63530018 |
| 58 | Chest pain (HP:0100749) | 2.61464991 |
| 59 | Insulin resistance (HP:0000855) | 2.61462622 |
| 60 | Plantar hyperkeratosis (HP:0007556) | 2.61245786 |
| 61 | Gingival bleeding (HP:0000225) | 2.60653617 |
| 62 | Hyperphosphatemia (HP:0002905) | 2.57981096 |
| 63 | Onycholysis (HP:0001806) | 2.56512440 |
| 64 | Recurrent cutaneous fungal infections (HP:0011370) | 2.55142009 |
| 65 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.55142009 |
| 66 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.54275418 |
| 67 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.54275418 |
| 68 | Abnormality of glycolipid metabolism (HP:0010969) | 2.54275418 |
| 69 | Type I transferrin isoform profile (HP:0003642) | 2.49738102 |
| 70 | Concave nail (HP:0001598) | 2.49592464 |
| 71 | Anorexia (HP:0002039) | 2.48440367 |
| 72 | Papilledema (HP:0001085) | 2.47596161 |
| 73 | Increased IgE level (HP:0003212) | 2.46309719 |
| 74 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.38694120 |
| 75 | Arterial thrombosis (HP:0004420) | 2.37277179 |
| 76 | Vasculitis (HP:0002633) | 2.36846081 |
| 77 | Abnormality of nail color (HP:0100643) | 2.36135908 |
| 78 | Hamartoma of the eye (HP:0010568) | 2.32903660 |
| 79 | Gangrene (HP:0100758) | 2.31025489 |
| 80 | Pancreatitis (HP:0001733) | 2.29557202 |
| 81 | Microcytic anemia (HP:0001935) | 2.29498626 |
| 82 | Testicular neoplasm (HP:0010788) | 2.27979809 |
| 83 | Mediastinal lymphadenopathy (HP:0100721) | 2.27669386 |
| 84 | Periodontitis (HP:0000704) | 2.27119732 |
| 85 | Interstitial pulmonary disease (HP:0006530) | 2.26673764 |
| 86 | Spontaneous hematomas (HP:0007420) | 2.25943791 |
| 87 | Conjunctival hamartoma (HP:0100780) | 2.24791972 |
| 88 | Hemoptysis (HP:0002105) | 2.24702305 |
| 89 | Progressive neurologic deterioration (HP:0002344) | 2.22225399 |
| 90 | Stomach cancer (HP:0012126) | 2.20871320 |
| 91 | Hyperactive renin-angiotensin system (HP:0000841) | 2.19022005 |
| 92 | Aqueductal stenosis (HP:0002410) | 2.18798314 |
| 93 | Petechiae (HP:0000967) | 2.18058688 |
| 94 | Pustule (HP:0200039) | 2.18028487 |
| 95 | Unilateral renal agenesis (HP:0000122) | 2.17655389 |
| 96 | Cheilitis (HP:0100825) | 2.16611084 |
| 97 | Abdominal distention (HP:0003270) | 2.16277936 |
| 98 | Palmoplantar hyperkeratosis (HP:0000972) | 2.16243780 |
| 99 | Retinal atrophy (HP:0001105) | 2.15625750 |
| 100 | Amyloidosis (HP:0011034) | 2.14656138 |
| 101 | Decreased subcutaneous fat (HP:0001002) | 2.14222354 |
| 102 | Type I diabetes mellitus (HP:0100651) | 2.13882763 |
| 103 | Growth hormone excess (HP:0000845) | 2.12437493 |
| 104 | Abnormality of the axillary hair (HP:0100134) | 2.07803536 |
| 105 | Abnormality of secondary sexual hair (HP:0009888) | 2.07803536 |
| 106 | Dysautonomia (HP:0002459) | 2.07030051 |
| 107 | Hypokalemia (HP:0002900) | 2.06997142 |
| 108 | Neoplasm of the adrenal cortex (HP:0100641) | 2.06043097 |
| 109 | Muscle fibrillation (HP:0010546) | 2.05821265 |
| 110 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.05604427 |
| 111 | Hypercortisolism (HP:0001578) | 2.03951158 |
| 112 | Leukocytosis (HP:0001974) | 2.03316956 |
| 113 | Milia (HP:0001056) | 2.03104951 |
| 114 | Popliteal pterygium (HP:0009756) | 2.03086071 |
| 115 | Gingivitis (HP:0000230) | 2.02062961 |
| 116 | Hypotension (HP:0002615) | 2.01830877 |
| 117 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.01596730 |
| 118 | Sepsis (HP:0100806) | 2.00962886 |
| 119 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.00651629 |
| 120 | Woolly hair (HP:0002224) | 1.98254481 |
| 121 | Abnormality of the common coagulation pathway (HP:0010990) | 1.94017548 |
| 122 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.92303008 |
| 123 | Villous atrophy (HP:0011473) | 1.92303008 |
| 124 | Palmar hyperkeratosis (HP:0010765) | 1.92043293 |
| 125 | Episodic fever (HP:0001954) | 1.91371473 |
| 126 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.91317380 |
| 127 | Increased cerebral lipofuscin (HP:0011813) | 1.90692742 |
| 128 | Pulmonary embolism (HP:0002204) | 1.89693974 |
| 129 | Oligomenorrhea (HP:0000876) | 1.88719404 |
| 130 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.88707206 |
| 131 | Beaking of vertebral bodies (HP:0004568) | 1.86780488 |
| 132 | Abnormality of subcutaneous fat tissue (HP:0001001) | 1.86497469 |
| 133 | Progressive inability to walk (HP:0002505) | 1.85693563 |
| 134 | Breast carcinoma (HP:0003002) | 1.85520272 |
| 135 | Conjugated hyperbilirubinemia (HP:0002908) | 1.83394451 |
| 136 | Parakeratosis (HP:0001036) | 1.82645875 |
| 137 | Agitation (HP:0000713) | 1.82512647 |
| 138 | Hypotrichosis (HP:0001006) | 1.80723256 |
| 139 | Keratitis (HP:0000491) | 1.80545463 |
| 140 | Osteomyelitis (HP:0002754) | 1.80471889 |
| 141 | Limb hypertonia (HP:0002509) | 1.79798948 |
| 142 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.79614306 |
| 143 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.79078119 |
| 144 | Curly hair (HP:0002212) | 1.77197377 |
| 145 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.77142856 |
| 146 | Thoracic kyphosis (HP:0002942) | 1.75640257 |
| 147 | Gout (HP:0001997) | 1.74459754 |
| 148 | Epistaxis (HP:0000421) | 1.73492053 |
| 149 | Macroorchidism (HP:0000053) | 1.73105292 |
| 150 | Cone-rod dystrophy (HP:0000548) | 1.73100943 |
| 151 | Bone cyst (HP:0012062) | 1.72683568 |
| 152 | Hypoplasia of dental enamel (HP:0006297) | 1.72492707 |
| 153 | Pancreatic cysts (HP:0001737) | 1.72200109 |
| 154 | Micronodular cirrhosis (HP:0001413) | 1.72107386 |
| 155 | Myositis (HP:0100614) | 1.71409392 |
| 156 | Reduced antithrombin III activity (HP:0001976) | 1.71257501 |
| 157 | Steatorrhea (HP:0002570) | 1.71004832 |
| 158 | Furrowed tongue (HP:0000221) | 1.70835379 |
| 159 | Abnormality of chloride homeostasis (HP:0011422) | 1.70608571 |
| 160 | Premature loss of primary teeth (HP:0006323) | 1.69698486 |
| 161 | Acute hepatic failure (HP:0006554) | 1.69680771 |
| 162 | Abnormality of T cell physiology (HP:0011840) | 1.69332133 |
| 163 | Hypoplasia of the odontoid process (HP:0003311) | 1.67372691 |
| 164 | Abnormality of the gastric mucosa (HP:0004295) | 1.66570472 |
| 165 | Congenital sensorineural hearing impairment (HP:0008527) | 1.66539505 |
| 166 | Fat malabsorption (HP:0002630) | 1.65706305 |
| 167 | Ventricular fibrillation (HP:0001663) | 1.65233623 |
| 168 | Widely spaced teeth (HP:0000687) | 1.65089823 |
| 169 | Erythroderma (HP:0001019) | 1.64283299 |
| 170 | Alveolar cell carcinoma (HP:0006519) | 1.62879629 |
| 171 | Pulmonary infiltrates (HP:0002113) | 1.62834595 |
| 172 | Hyperventilation (HP:0002883) | 1.62599606 |
| 173 | Papillary thyroid carcinoma (HP:0002895) | 1.62018593 |
| 174 | Macular degeneration (HP:0000608) | 1.62007948 |
| 175 | Increased CSF protein (HP:0002922) | 1.61936074 |
| 176 | Choroideremia (HP:0001139) | 1.61450869 |
| 177 | Skin ulcer (HP:0200042) | 1.58287714 |
| 178 | Erythema (HP:0010783) | 1.57327506 |
| 179 | Abnormality of the pleura (HP:0002103) | 1.56618507 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | INSRR | 4.52761045 |
| 2 | ERN1 | 4.44660569 |
| 3 | TAOK3 | 4.31397850 |
| 4 | FRK | 3.28062314 |
| 5 | TNK2 | 3.26251454 |
| 6 | SIK3 | 2.99241557 |
| 7 | MAPKAPK3 | 2.93464714 |
| 8 | MAP3K2 | 2.83362195 |
| 9 | BCKDK | 2.81088914 |
| 10 | GRK6 | 2.65851316 |
| 11 | PASK | 2.60218069 |
| 12 | IRAK3 | 2.58748619 |
| 13 | MAPK15 | 2.43619214 |
| 14 | TRIM28 | 2.06178441 |
| 15 | IRAK4 | 2.06175185 |
| 16 | TRIB3 | 2.03770790 |
| 17 | EPHA3 | 1.91865271 |
| 18 | MAP4K1 | 1.91408373 |
| 19 | TAOK1 | 1.88964070 |
| 20 | HIPK2 | 1.86662118 |
| 21 | FES | 1.85637679 |
| 22 | MAP3K3 | 1.83206714 |
| 23 | MAP2K2 | 1.81738641 |
| 24 | YES1 | 1.80112070 |
| 25 | MST1R | 1.75242915 |
| 26 | FLT3 | 1.66959790 |
| 27 | NTRK1 | 1.58475565 |
| 28 | MAP3K1 | 1.53026442 |
| 29 | FGR | 1.45486184 |
| 30 | EIF2AK3 | 1.42759622 |
| 31 | NUAK1 | 1.41760355 |
| 32 | PIK3CG | 1.41059852 |
| 33 | TRPM7 | 1.36702853 |
| 34 | JAK3 | 1.36474645 |
| 35 | ZAP70 | 1.34327185 |
| 36 | HCK | 1.32956961 |
| 37 | MST4 | 1.31566734 |
| 38 | PTK2B | 1.23071456 |
| 39 | EEF2K | 1.20933742 |
| 40 | FGFR2 | 1.20645497 |
| 41 | PTK6 | 1.16220035 |
| 42 | CSF1R | 1.16161745 |
| 43 | FER | 1.14848608 |
| 44 | LATS1 | 1.13059675 |
| 45 | OXSR1 | 1.11038950 |
| 46 | MAP3K14 | 1.09466556 |
| 47 | PAK3 | 1.08449699 |
| 48 | MATK | 1.07621052 |
| 49 | SIK1 | 1.05316869 |
| 50 | DAPK2 | 1.04110832 |
| 51 | PIM2 | 1.03514811 |
| 52 | GRK1 | 1.03286450 |
| 53 | AKT3 | 1.02602374 |
| 54 | RPS6KA2 | 1.01561459 |
| 55 | TESK1 | 1.01471489 |
| 56 | JAK2 | 0.99674217 |
| 57 | RET | 0.99167319 |
| 58 | JAK1 | 0.99116852 |
| 59 | ACVR1B | 0.99016141 |
| 60 | RIPK4 | 0.98786915 |
| 61 | BMPR2 | 0.98268687 |
| 62 | MAPK13 | 0.97956423 |
| 63 | KIT | 0.96348734 |
| 64 | LYN | 0.93051184 |
| 65 | TYK2 | 0.92313261 |
| 66 | TXK | 0.91766118 |
| 67 | PTK2 | 0.91529653 |
| 68 | IRAK1 | 0.90602320 |
| 69 | TEC | 0.89482421 |
| 70 | MAP2K1 | 0.89024860 |
| 71 | CAMKK2 | 0.87617436 |
| 72 | MAP2K3 | 0.87548913 |
| 73 | BTK | 0.86528025 |
| 74 | MARK3 | 0.84469012 |
| 75 | MAP2K4 | 0.82969421 |
| 76 | TBK1 | 0.81758059 |
| 77 | MAP4K2 | 0.80772511 |
| 78 | KSR2 | 0.79798626 |
| 79 | SGK2 | 0.79266344 |
| 80 | WNK3 | 0.79058884 |
| 81 | FGFR3 | 0.78871241 |
| 82 | STK11 | 0.78072283 |
| 83 | NME2 | 0.77650096 |
| 84 | BLK | 0.76622023 |
| 85 | SCYL2 | 0.74767842 |
| 86 | STK24 | 0.74289749 |
| 87 | STK10 | 0.73469427 |
| 88 | LRRK2 | 0.72788599 |
| 89 | MET | 0.68829263 |
| 90 | SGK3 | 0.68742276 |
| 91 | PDGFRA | 0.68416972 |
| 92 | PDK1 | 0.67846998 |
| 93 | LCK | 0.65551488 |
| 94 | WNK4 | 0.65230153 |
| 95 | EPHB1 | 0.65152101 |
| 96 | DYRK3 | 0.63542718 |
| 97 | PRKCZ | 0.63431953 |
| 98 | BMPR1B | 0.63249889 |
| 99 | RIPK1 | 0.61690024 |
| 100 | BRAF | 0.60698301 |
| 101 | PKN2 | 0.60000814 |
| 102 | ERBB3 | 0.59897109 |
| 103 | PRKD3 | 0.59158010 |
| 104 | MAP2K6 | 0.57396549 |
| 105 | TAF1 | 0.56804258 |
| 106 | PRKCI | 0.56386893 |
| 107 | NLK | 0.54630158 |
| 108 | CSK | 0.54496727 |
| 109 | PRKCQ | 0.53875689 |
| 110 | STK39 | 0.52927939 |
| 111 | NEK6 | 0.52125895 |
| 112 | RPS6KB1 | 0.51219113 |
| 113 | IKBKE | 0.50999189 |
| 114 | PRKG2 | 0.50794846 |
| 115 | MARK2 | 0.50705714 |
| 116 | FGFR4 | 0.48953397 |
| 117 | ARAF | 0.48311275 |
| 118 | DYRK1B | 0.47185257 |
| 119 | IRAK2 | 0.46330081 |
| 120 | TGFBR2 | 0.46289286 |
| 121 | MAP3K6 | 0.46091225 |
| 122 | MAP3K11 | 0.45585690 |
| 123 | PDPK1 | 0.45276777 |
| 124 | CHUK | 0.45243338 |
| 125 | MYLK | 0.45108779 |
| 126 | ITK | 0.44918925 |
| 127 | STK38 | 0.43282654 |
| 128 | PRKCH | 0.42699213 |
| 129 | PINK1 | 0.42570117 |
| 130 | LMTK2 | 0.40865168 |
| 131 | BCR | 0.38993268 |
| 132 | IGF1R | 0.38176647 |
| 133 | CASK | 0.37733152 |
| 134 | PDGFRB | 0.36639798 |
| 135 | SYK | 0.36541914 |
| 136 | RPS6KB2 | 0.36200506 |
| 137 | PRKCE | 0.35095924 |
| 138 | NEK9 | 0.34744970 |
| 139 | MAPKAPK2 | 0.34103588 |
| 140 | RPS6KC1 | 0.33841288 |
| 141 | RPS6KL1 | 0.33841288 |
| 142 | BRSK2 | 0.33448478 |
| 143 | IKBKB | 0.32405414 |
| 144 | RPS6KA6 | 0.31082219 |
| 145 | MAP3K12 | 0.30286278 |
| 146 | ADRBK1 | 0.27949983 |
| 147 | PRKD2 | 0.27831478 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 6.52972058 |
| 2 | Protein export_Homo sapiens_hsa03060 | 4.79095950 |
| 3 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 3.15768323 |
| 4 | * Pancreatic secretion_Homo sapiens_hsa04972 | 3.00468066 |
| 5 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.74649947 |
| 6 | Other glycan degradation_Homo sapiens_hsa00511 | 2.49191928 |
| 7 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.16825664 |
| 8 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.05237711 |
| 9 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 2.04550678 |
| 10 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.03620616 |
| 11 | Lysosome_Homo sapiens_hsa04142 | 1.90603955 |
| 12 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.87538403 |
| 13 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.77113603 |
| 14 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.70015872 |
| 15 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.69933170 |
| 16 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.68600437 |
| 17 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.64217576 |
| 18 | Insulin secretion_Homo sapiens_hsa04911 | 1.62006126 |
| 19 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.52597582 |
| 20 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.40638685 |
| 21 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.40483104 |
| 22 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.39362133 |
| 23 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.37056590 |
| 24 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.32574352 |
| 25 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.29942719 |
| 26 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.25856295 |
| 27 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.24262431 |
| 28 | Legionellosis_Homo sapiens_hsa05134 | 1.21752537 |
| 29 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.21630336 |
| 30 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 1.20208320 |
| 31 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.18342041 |
| 32 | Leishmaniasis_Homo sapiens_hsa05140 | 1.17578700 |
| 33 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.16118663 |
| 34 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.15710764 |
| 35 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.14944814 |
| 36 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.08733593 |
| 37 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.07535965 |
| 38 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.07049014 |
| 39 | Endocytosis_Homo sapiens_hsa04144 | 1.06859661 |
| 40 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.06556505 |
| 41 | Insulin resistance_Homo sapiens_hsa04931 | 1.05456951 |
| 42 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.03481369 |
| 43 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.01853440 |
| 44 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.01750515 |
| 45 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.01178837 |
| 46 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.00512035 |
| 47 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.97239218 |
| 48 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.95586124 |
| 49 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.95276786 |
| 50 | Pertussis_Homo sapiens_hsa05133 | 0.95189429 |
| 51 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.94781822 |
| 52 | Malaria_Homo sapiens_hsa05144 | 0.94577455 |
| 53 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.93139727 |
| 54 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.92756843 |
| 55 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.88175205 |
| 56 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.86794792 |
| 57 | Thyroid cancer_Homo sapiens_hsa05216 | 0.86518860 |
| 58 | Allograft rejection_Homo sapiens_hsa05330 | 0.85784211 |
| 59 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.83822951 |
| 60 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.83242613 |
| 61 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.83076395 |
| 62 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.82468186 |
| 63 | Phagosome_Homo sapiens_hsa04145 | 0.82237745 |
| 64 | Influenza A_Homo sapiens_hsa05164 | 0.81114431 |
| 65 | Tuberculosis_Homo sapiens_hsa05152 | 0.80210207 |
| 66 | Galactose metabolism_Homo sapiens_hsa00052 | 0.80043279 |
| 67 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.78810310 |
| 68 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.78559410 |
| 69 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.74121798 |
| 70 | Phototransduction_Homo sapiens_hsa04744 | 0.73148197 |
| 71 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.73134269 |
| 72 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.72480097 |
| 73 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.72392759 |
| 74 | Histidine metabolism_Homo sapiens_hsa00340 | 0.72378694 |
| 75 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.71900868 |
| 76 | Circadian rhythm_Homo sapiens_hsa04710 | 0.69609864 |
| 77 | Shigellosis_Homo sapiens_hsa05131 | 0.69305529 |
| 78 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.68707059 |
| 79 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.68347542 |
| 80 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.65720273 |
| 81 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.65403752 |
| 82 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.63806884 |
| 83 | ABC transporters_Homo sapiens_hsa02010 | 0.63122805 |
| 84 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.63072944 |
| 85 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.62300231 |
| 86 | Hepatitis B_Homo sapiens_hsa05161 | 0.62202975 |
| 87 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.61536847 |
| 88 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.61373147 |
| 89 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.59083550 |
| 90 | Hepatitis C_Homo sapiens_hsa05160 | 0.58212134 |
| 91 | Endometrial cancer_Homo sapiens_hsa05213 | 0.57763234 |
| 92 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.57562822 |
| 93 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.57143948 |
| 94 | Amoebiasis_Homo sapiens_hsa05146 | 0.57141554 |
| 95 | Peroxisome_Homo sapiens_hsa04146 | 0.55561796 |
| 96 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.54033086 |
| 97 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.52819560 |
| 98 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.51157663 |
| 99 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.50525392 |
| 100 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.49556777 |
| 101 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.49131916 |
| 102 | Long-term depression_Homo sapiens_hsa04730 | 0.48224647 |
| 103 | Bladder cancer_Homo sapiens_hsa05219 | 0.47930814 |
| 104 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.47879281 |
| 105 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.46818231 |
| 106 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.46273717 |
| 107 | Cocaine addiction_Homo sapiens_hsa05030 | 0.46016365 |
| 108 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.45523293 |
| 109 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.44270260 |
| 110 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.43967668 |
| 111 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.43307409 |
| 112 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.43281448 |
| 113 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.42562412 |
| 114 | Apoptosis_Homo sapiens_hsa04210 | 0.42504454 |
| 115 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.42400668 |
| 116 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.42133360 |
| 117 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.41800563 |
| 118 | Colorectal cancer_Homo sapiens_hsa05210 | 0.40770154 |
| 119 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.40106126 |
| 120 | Prostate cancer_Homo sapiens_hsa05215 | 0.39444113 |
| 121 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.39243675 |
| 122 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.38661320 |
| 123 | Platelet activation_Homo sapiens_hsa04611 | 0.38653064 |
| 124 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.38095339 |
| 125 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.37996932 |
| 126 | Salmonella infection_Homo sapiens_hsa05132 | 0.37925506 |
| 127 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.34332202 |
| 128 | Measles_Homo sapiens_hsa05162 | 0.34018334 |
| 129 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.32331974 |
| 130 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.31487136 |
| 131 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.31476851 |
| 132 | Taste transduction_Homo sapiens_hsa04742 | 0.30634689 |
| 133 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.29977660 |
| 134 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.29934563 |
| 135 | Adherens junction_Homo sapiens_hsa04520 | 0.29681619 |
| 136 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.29589912 |
| 137 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.29293603 |
| 138 | Mineral absorption_Homo sapiens_hsa04978 | 0.28219482 |
| 139 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.28037338 |
| 140 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.27839598 |
| 141 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.27783943 |

